Ihealth
1 known investors
iHealth develops connected consumer medical devices and at-home diagnostic tests, including COVID-19 rapid antigen tests.
Also known as iHealth Labs · iHealth Labs Inc
Founders & leadership
Investors · 1
Company profile
researched Aug 2026iHealth (iHealth Labs Inc) designs and sells consumer healthcare products and connected vitals-monitoring devices. Its catalogue includes wireless and connected blood pressure monitors (Neo, Jurni, Track, Track Pro), the Gluco+ wireless smart glucose monitoring system, body composition scales (Nexus Pro, Core), pulse oximeters, infrared no-touch forehead thermometers, a dual-channel TENS unit, a smart water flosser and a bug bite healer. Devices are paired with a companion smartphone app; the company was an early entrant in iOS-connected health hardware, releasing an iOS-connected blood pressure monitor and integrating nine of its mobile health devices into Apple's HealthKit.
The company also sells at-home diagnostic tests, including an FDA-authorized COVID-19 antigen rapid test, a Flu A&B/COVID-19 3-in-1 rapid test and an RSV/COVID-19/Flu A&B 4-in-1 rapid test. During the COVID-19 pandemic iHealth became a major supplier of at-home tests to the U.S. federal government as well as to states and cities, after previously focusing on medical devices such as forehead thermometers. iHealth is associated with the Andon Group, whose chairman, Mr. Liu, is also described as the founder of iHealth.
Business model
iHealth sells hardware and diagnostic test kits directly to consumers through its own e-commerce site and retail/marketplace channels such as Amazon, with options including multi-test packs, product bundles and auto-refill subscriptions. It also supplies at-home test kits in volume to government buyers, including the U.S. federal government and state and local authorities.
Product sales of consumer medical devices, accessories and diagnostic test kits, sold individually, in multi-packs and bundles, and through auto-refill subscriptions, supplemented by government procurement contracts for test kits.
Traction
Press coverage reported a $1.3 billion U.S. federal contract for rapid tests plus an additional order of nearly 105 million test kits, and the company cites test volumes supplied through federal government contracts along with Circana and Amazon sales data since 2022.
Latest developments
iHealth continues to expand its at-home testing line with a Flu A&B/COVID-19 3-in-1 rapid test and an RSV/COVID-19/Flu A&B 4-in-1 rapid test, and has introduced the PT9S no-touch thermometer with infant, child, adult and object modes alongside devices such as the Soothe dual-channel TENS unit and VESA smart water flosser.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
iHealth describes itself as a leader in medical supply innovation since 2010 and was characterized in press coverage as the U.S. administration's biggest rapid-test bet, becoming a major supplier to the federal government as well as states and cities despite not having made a rapid test before late 2021. Its 2016 eDevice acquisition was positioned as creating the world's largest connected healthcare provider.
iHealth combines a design-focused connected device portfolio with app integration and, following the eDevice acquisition, in-house health data connectivity capability; its products are noted for design, reliable performance and affordability, and its test kits carry FDA authorization and FSA/HSA eligibility.
Technology
App-connected vitals monitoring hardware, including wireless and cordless blood pressure monitors, wireless glucose monitoring, body composition scales and pulse oximetry, each paired with a free companion smart device app and, historically, Apple HealthKit integration. Its diagnostic line uses lateral-flow style rapid antigen tests returning results in 15 minutes, including FDA-authorized COVID-19 tests and multiplex flu/COVID/RSV tests. Through the eDevice acquisition it added data transmission and connectivity technology used by companies such as Medtronic and Philips.
Go-to-market
Direct-to-consumer e-commerce on its own website with promotional pricing, bundles and subscriptions, plus sales via Amazon; large-scale public-sector supply contracts for at-home COVID-19 tests; and partnership-based distribution such as the Rockefeller Foundation program with CareEvolution, Amazon and six state health departments to deliver free COVID-19 tests.
Consumers and families managing health at home, including people monitoring blood pressure, blood glucose and weight, and buyers of at-home respiratory infection tests; also government public health agencies procuring at-home test kits for distribution.
Geography
The company is based in Sunnyvale, California, and its parent, the Andon Group, is described as having a strong presence in Europe, the United States and China. Its 2016 acquisition target eDevice was headquartered in Bordeaux, France.
History
Founded in 2010, iHealth was the first to release an iOS-connected blood pressure monitor and integrated nine of its mobile health devices into Apple's HealthKit. It expanded into a broader line of connected devices including glucometers, wireless scales, pulse oximeters and the iHealth Edge activity tracker. In 2016 it acquired Bordeaux, France-based data connectivity specialist eDevice for $106 million, a deal the companies said would create the largest connected healthcare provider in the world. Beginning in late 2021 the company added rapid at-home COVID-19 antigen testing and became a principal supplier to U.S. federal, state and local government programs.
Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 5
launches, deals, and filingsiHealth introduced the PT9S no-touch forehead thermometer with infant, child, adult and object modes, alongside a Flu A&B/COVID-19 3-in-1 rapid test and an RSV/COVID-19/Flu A&B 4-in-1 rapid test.
iHealth acquired Bordeaux, France-based data connectivity specialist eDevice for $106 million, a combination the companies said would create the largest connected healthcare provider in the world. eDevice co-founders Stephane Schinazi and Marc Berrebi continued to lead eDevice and took strategic advisory roles in the Andon Group.
$106M source ↗
The U.S. administration awarded iHealth a $1.3 billion contract for at-home rapid COVID-19 tests and subsequently ordered nearly 105 million additional test kits; iHealth also supplied states and cities.
$1.3B source ↗
The Rockefeller Foundation partnered with iHealth Labs, CareEvolution, Amazon and six state health departments to deliver free COVID-19 tests.
iHealth released the first iOS-connected blood pressure monitor and integrated nine of its mobile health devices into Apple's HealthKit, later expanding to glucometers, wireless scales, the iHealth Edge activity tracker and a wireless pulse oximeter.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 6
primary sources listed
- iHealth Labs – iHealth Labs Incihealthlabs.com · web
6 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Ihealth do?
- iHealth develops connected consumer medical devices and at-home diagnostic tests, including COVID-19 rapid antigen tests.
- Who founded Ihealth?
- Ihealth was founded by Yi Liu.
- Who are Ihealth's investors?
- Ihealth's investors include AppWorks Ventures.